Skip to content

Corvel CRVL Cash received from option exercises

Cash received from option exercises at other companies

SS&C Technologies logo
SS&C TechnologiesSSNC
$22.3M-88.9%
CVS Health logo
CVS HealthCVS

Other financials

Income statement

See full
Revenue$248.5M+7.4%
Gross profit$63.0M+8.3%
Net income$31.0M+17.4%
EPS (diluted)$0.61+19.6%

Balance sheet

See full
Cash & equivalents$233.1M+36.6%
Total debt$28.1M+0.1%
Total equity$394.2M+22.4%
Total assets$643.0M+17.8%

Cash flow

See full
Operating cash flow$29.5M+28.6%
CapEx$9.2M+5.9%
Free cash flow$20.3M+42.3%

Valuation

See full
Market cap$3.03B-51.4%
Enterprise value$2.82B-53.8%
P/E27.4×-38.0×
P/S3.2×-3.8×

Profitability

See full
Gross margin24.3%+0.9pp
Net margin11.5%+0.9pp
FCF margin11.5%+1.3pp

Returns & leverage

See full
Return on equity30.8%-2.6pp
Debt / equity0.1×0.0×
Current ratio+0.1×

Where this comes from

Reported directly by Corvel in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: Corvel’s 10-K, filed May 22, 2026, on SEC EDGAR. View the filing →

Ask your AI about Corvel's cash received from option exercises.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Corvel's cash received from option exercises?
Corvel (CRVL) reported cash received from option exercises of $2.51M in Q1 2026.
How has Corvel's cash received from option exercises changed year-over-year?
Corvel's cash received from option exercises increased by 27.6% year-over-year, from $1.97M to $2.51M.
What is the long-term trend for Corvel's cash received from option exercises?
Over 4 years (2022 to 2026), Corvel's cash received from option exercises has grown at a -6.5% compound annual growth rate (CAGR), from $9.91M to $7.56M.